JC Decaux

Modelling (again) the impact of COVID-19

26/03/20 -"We have revised our forecasts downwards again, after the group indicated its Q1 guidance (-10% organic) is no longer valid and that Q2 will be worse, with the COVID-19 crisis spreading in Europe and ..."

Published on
You may also be interested by these reports :
RELX just released a trading statement ahead of is 23 April 2020 AGM to inform that it has suspended both its FY20e guidance and share buy-back due ...

Joseph Oughourlian, founder of Amber Capital and Olivier Fortesa, Managing Partner, held a meeting this morning in order to explain a number of major ...

Our target price moves from €10 to €11.40 after we updated our model in the aftermath of the FY19 annual report release. We have integrated within ...

The cut in the target price is due to the downgrade of our estimates with an impact on the DCF, the NAV and the comparison-based valuations. The ...


Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis


AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO